Skip to main content
. 2014 Mar 5;9(3):e89123. doi: 10.1371/journal.pone.0089123

Table 4. Literatures of interaction between compounds and targets.

Compounds Targets
Emodin Monoamine oxidase B [145], Hypoxia-inducible factor 1α [121], [158], Thymidine phosphorylase [136], Macrophage metalloelastase [123], Interleukin 8 [123], Tumor necrosis factor ligand superfamily member 5 [123]
Rhein Monoamine oxidase B [145], Protein Tyrosine Phosphatase [141], Hypoxia-inducible factor 1α [137], Epidermal growth factor receptor [137]
Chrysorphanol Monoamine oxidase B [145], Protein Tyrosine Phosphatase [141]
Aloe-emodin Monoamine oxidase B [145]
Physcion Monoamine oxidase B [145], Protein Tyrosine Phosphatase [141]
Gallic Acid 3-O-β-D- Gluco- pyranoside Hypoxia-inducible factor 1α [159]
Salvianolic acid B Tissue plasminogen activator [132], Plasminogen activator inhibitor-1 [132], Angiotensin converting enzyme [140]
Tanshinone IIA Transforming growth factor beta 1 [134], [160], Angiotensin converting enzyme [134], Peroxisome proliferator-activated receptor [161], [162]
Calycosin Estrogen receptor [94]
Formononetin Monoamine oxidase B [146], Mitogen-activated protein kinase 14 [135]
Quercetin β2 adrenergic receptor [163], Interleukin 8 [139],Tumor necrosis factor ligand superfamily member 5 [138], C-C motif chemokine-2 [138], Nuclear factor NF-κB [139], Jun proto-oncogene [138]
Curcumin β2 adrenergic receptor [164], [165], Insulin receptor [92], C-C motif chemokine-2 [91], Interleukin 8 [91], Transforming growth factor beta 1 [92], Plasminogen activator inhibitor-1 [92], Fibronectin 1 [92]